Media mentions and company announcements
Affect Expands Into Mental Health Treatment Services Affect Therapeutics, the leading digital health provider for addiction recovery, is expanding its services to include comprehensive mental health care — starting in…
read moreAffect Therapeutics Joins King County Integrated Care Network to Expand Access to Digital Substance Use Disorder Treatment Affect Therapeutics, the leading provider of fully virtual, evidence-based substance use disorder (SUD)…
read moreComing Soon A survey team from CARF International* will be visiting on September 26 to September 27 We invited the surveyors to evaluate how well we meet international standards for…
read moreJon Peeples, MD, Affect's Chief Medical Officer, talked to Morgan Gonzales of
read moreDigital innovation bridges the addiction treatment gap Health Tech World interviews Affect's CEO Joe Roberts of Health Tech World recently
read moreNewsmedia Report on Affect Therapeutics' Series A Funding Multiple news stories have been published covering our recent announcement of our $16 million series A fundraising round. Here are a few:Fortune…
read moreDelivering Next Generation Addiction Recovery, Affect Therapeutics Raises $16 Million in Series A Funding Led by ARTIS Ventures Smartphone app for drug and alcohol addiction offers a portable, personalized and…
read moreAffect Launches New Program for Cannabis Use Disorder Building on the success with alcohol and stimulant use disorders, Affect's digital program offers a solution to a growing problem In the…
read moreAffect Receives the Highest Level of CARF Accreditation Our digital program stands alone in recognition of quality, results, and commitment to treating addiction We're thrilled to announce that, in recognition…
read moreAffect Therapeutics Aims to Curb Stimulant Addiction: Treatment Magazine Jason Langendorf writes in
read more
